Atossa Therapeutics Inc —— 季度财务数据 (NASDAQ:ATOS)

Financials

经营活动产生的现金 -7.05 M-5.96 M-7.26 M-6 M-10.54 M -29.76 M 投资活动产生的现金 0-9 0000-7 000-7 000 -23 K 融资活动产生的现金 3.37 M0000 0 自由现金流 -7.05 M-5.97 M-7.26 M-6.01 M-10.55 M -29.79 M

新闻

France stocks lower at close of trade; CAC 40 down 0.67%

法国股市收低；截至收盘法国CAC40指数下跌0.67%

France stocks higher at close of trade; CAC 40 up 0.92%

France stocks lower at close of trade; CAC 40 down 0.87%

法国股市收低；截至收盘法国CAC40指数下跌0.87%

France stocks higher at close of trade; CAC 40 up 1.33%

法国股市上涨；截至收盘法国CAC40指数上涨1.33%

France stocks higher at close of trade; CAC 40 up 0.31%

法国股市上涨；截至收盘法国CAC40指数上涨0.31%

Atossa presents preclinical data on endoxifen for muscular dystrophy

France stocks lower at close of trade; CAC 40 down 0.19%

法国股市收低；截至收盘法国CAC40指数下跌0.19%